import React from "react";

export default function CEOLetter() {
  return (
    <div className="flex flex-col">
      <div className="mb-3 w-full text-left text-5xl _font-bold leading-tight tracking-tight text-black">
        CEOâ€™s letter
      </div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        2022 was a year of transformation for Novartis. After more than USD 100
        billion in acquisitions and divestures over the last several years, our
        structural transformation from a diversified healthcare conglomerate
        into a focused, innovative medicines company will be largely complete
        after the planned spin-off of Sandoz in 2023.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        We are investing in data science and technology to support innovation,
        increase efficiency, better respond to the needs of patients and
        healthcare professionals, and ultimately improve the way we develop and
        deliver our medicines.
      </div>
      <div className="py-4"></div>
      <img src="https://www.reporting.novartis.com/2022/_assets/gallery/06-narasimhan.jpg" />
      <div className="py-5"></div>
      <div className="mb-5 w-full text-left font-extralight text-3xl italic leading-tight text-[#0460a9]">
        As we look to the future as a focused medicines company, our dedication
        to innovation and excellence will drive us forward
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        2022 was a year of transformation for Novartis. After more than USD 100
        billion in acquisitions and divestures over the last several years, our
        structural transformation from a diversified healthcare conglomerate
        into a focused, innovative medicines company will be largely complete
        after the planned spin-off of Sandoz in 2023.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        We are investing in data science and technology to support innovation,
        increase efficiency, better respond to the needs of patients and
        healthcare professionals, and ultimately improve the way we develop and
        deliver our medicines.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        2022 was a year of transformation for Novartis. After more than USD 100
        billion in acquisitions and divestures over the last several years, our
        structural transformation from a diversified healthcare conglomerate
        into a focused, innovative medicines company will be largely complete
        after the planned spin-off of Sandoz in 2023.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        We are investing in data science and technology to support innovation,
        increase efficiency, better respond to the needs of patients and
        healthcare professionals, and ultimately improve the way we develop and
        deliver our medicines.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        2022 was a year of transformation for Novartis. After more than USD 100
        billion in acquisitions and divestures over the last several years, our
        structural transformation from a diversified healthcare conglomerate
        into a focused, innovative medicines company will be largely complete
        after the planned spin-off of Sandoz in 2023.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        We are investing in data science and technology to support innovation,
        increase efficiency, better respond to the needs of patients and
        healthcare professionals, and ultimately improve the way we develop and
        deliver our medicines.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        2022 was a year of transformation for Novartis. After more than USD 100
        billion in acquisitions and divestures over the last several years, our
        structural transformation from a diversified healthcare conglomerate
        into a focused, innovative medicines company will be largely complete
        after the planned spin-off of Sandoz in 2023.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        We are investing in data science and technology to support innovation,
        increase efficiency, better respond to the needs of patients and
        healthcare professionals, and ultimately improve the way we develop and
        deliver our medicines.
      </div>
      <div className="py-4"></div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        Sincerely,
      </div>
      <div className="py-4"></div>
      <img className="w-fit mb-3" src="https://www.reporting.novartis.com/2022/_assets/gallery/signature-ceo.svg" />

      <div className="w-full text-left _font-bold text-lg leading-relaxed tracking-normal text-black">
        Vas Narasimhan
      </div>
      <div className="w-full text-left text-lg leading-relaxed tracking-normal text-black">
        Chief Executive Officer
      </div>
    </div>
  );
}
